A simple, feasible, efficient and safe treatment strategy of sofosbuvir/velpatasvir for chronic HCV/HIV-1 coinfected patients regardless of HCV genotypes: a multicenter, open-label study in China

BACKGROUND: The direct-acting antiviral agents (DAAs) have revolutionized the treatment of Hepatitis C Virus (HCV) infection. However, a simple and feasible treatment strategy with high efficacy and safety for HCV in patients coinfected with Human Immunodeficiency Virus (HIV) remains an unmet medica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Weiyin, Wang, Xicheng, Zhang, Jianbo, Wen, Chunyan, Kang, Wen, Mao, Lin, Yang, Jie, Dou, Yanyun, Shi, Liying, Dang, Bianli, Lan, Yun, Li, Hong, Li, Yonghong, Chen, Xiejie, He, Haolan, Xu, Min, He, Yaozu, Hu, Fengyu, Lu, Ruichao, Cai, Weiping, Li, Linghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398601/
https://www.ncbi.nlm.nih.gov/pubmed/37547041
http://dx.doi.org/10.1016/j.lanwpc.2023.100749

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10398601/
https://www.ncbi.nlm.nih.gov/pubmed/37547041
http://dx.doi.org/10.1016/j.lanwpc.2023.100749

Ejemplares similares